Analysis of Catechin Content of Commercial Green Tea Products

References

• Zeisel S H. Regulation of “nutraceuticals.”. Science 1999; 285: 1853–5
   PubMed Web of Science ®Google Scholar
• Yang C S, Maliaka P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 2002; 42: 25–54
   PubMed Web of Science ®Google Scholar
• Dalluge J J, Nelson B C, Thomas J B, Sander L C. Selection of column and gradient elution system for the separation of catechins in green tea using high-performance liquid chromatography. J Chromatogr A. 1998; 793: 265–74
   PubMed Web of Science ®Google Scholar
• Wiseman S A, Balentine D A, Frei B. Antioxidants in tea. Crit Rev Food Sci Nutr. 1997; 37: 705–18
   PubMed Web of Science ®Google Scholar
• Buetler T M, Renard M, Offord E A, Schneider H, Ruegg U T. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am J Clin Nutr. 2002; 75: 749–53
   PubMed Web of Science ®Google Scholar
• Takada M, Nakamura Y, Koizumi T, Toyama H, Kamigaki T, Suzuki Y, Takeyama Y, Kuroda Y. Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas. 2002; 25: 45–8
   PubMed Web of Science ®Google Scholar
• Takada M, Ku Y, Habara K, Ajkik T, Suzuki Y, Kuroda Y. Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells. World J Surg. 2002; 26: 683–6
   PubMed Web of Science ®Google Scholar
• Jung Y D, Ellis L M. Inhibition of tumour invasion and angiogenesis by epigal-locatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol. 2001; 82: 309–16
   PubMed Web of Science ®Google Scholar
• Pianetti S, Guo S, Kavanagh K T, Sonenshein G E. Green tea polyphenol epigallocatechin-3-gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 2002; 62: 652–5
   PubMed Web of Science ®Google Scholar
• Hwang K C, Lee K H, Jang Y, Yun Y P, Chung K H. Epigallocatechin-3-gallate inhibits basic fibroblast growth factor-induced intracellular signaling transduction pathway in rat aortic smooth muscle cells. J Cardiovasc Pharmacol. 2002; 39: 271–7
   PubMed Web of Science ®Google Scholar
• Jankun J, Selman S H, Swiercz R, Skrzypcsak-Jankun E. Why drinking green tea could prevent cancer. Nature 1997; 387: 561
   PubMed Web of Science ®Google Scholar
• Ahmad N, Mukhtar H. Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev. 1999; 57: 78–83
   PubMed Web of Science ®Google Scholar
• Zhang M, Binns C W, Lee A H. Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomark Prev. 2002; 11: 713–8
   PubMed Web of Science ®Google Scholar
• Su L J, Arab L. Tea consumption and the reduced risk of colon cancer-results from a national prospective cohort study. Public Health Nutr. 2002; 5: 419–25
   PubMed Web of Science ®Google Scholar
• Yee Y K, Koo M W, Szeto M L. Chinese tea consumption and lower risk of Helicobacter infection. J Gastroenterol Hepatol. 2002; 17: 552–5
   PubMed Web of Science ®Google Scholar
• Ohmori Y, Ito M, Kishi M, Mizutani H, Katada T, Konishi H. Antiallergic constituents from oolong tea stem. Biol Pharm Bull. 1995; 18: 683–6
   PubMed Web of Science ®Google Scholar
• Hibasami H, Achiwa Y, Fjuikawa T, Komiya T. Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anti-cancer Res. 1996; 16: 1943–6
   PubMed Web of Science ®Google Scholar
• Nakane H, Ono K. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry 1990; 29: 2841–5
   PubMed Web of Science ®Google Scholar
• Wu C H, Yang Y C, Yao W J, Lu F H, Wu J S, Chang C J. Epidemiological evidence of increased bone mineral density in habitual tea drinkers. Arch Intern Med. 2002; 162: 1001–6
   PubMed Web of Science ®Google Scholar
• Riemersma R A, Rice-Evans C A, Tyrrell R M, Clifford M N, Lean M E. Tea flavonoids and cardiovascular health. QJM. 2001; 94: 277–82
   PubMed Web of Science ®Google Scholar
• Geleijnse J M, Launer J L, van der Kuip D AM, Hofman A, Witteman J CM. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam study. Am J Clin Nutr. 2002; 75: 880–6
   PubMed Web of Science ®Google Scholar
• Sagesake-Mitane Y, Miwa M, Okada S. Platelet aggregation inhibitors in hot water extract of green tea. Chem Pharm Bull (Tokyo). 1990; 38: 790–3
   PubMed Web of Science ®Google Scholar
• Miura Y, Chiba T, Miura S, Tomita I, Umegaki K, Ikeda M, Tomita T. Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipo-proteins: an ex vivo study in humans. J Nutr Biochem. 2000; 11: 216–22
   PubMed Web of Science ®Google Scholar
• Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, Hara Y, Ikeda M, Tomita T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001; 131: 27–32
   PubMed Web of Science ®Google Scholar
• Locher R, Emmanuele L, Suter P M, Vetter W, Barton M. Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. Eur J Pharmacol. 2002; 434: 1–7
   PubMed Web of Science ®Google Scholar
• Sasazuki S, Kodama H, Yoshimasu K, Liu Y, Washio M, Tanaka K, Tokunaga S, Kono S, Arai H, Doi Y, Kawano T, Nakagaki O, Takada K, Koyanagi S, Hiyamuta K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol. 2000; 10: 401–8
   PubMed Web of Science ®Google Scholar
• The Merck index, 11th edition, S Budavari. Merck & Co., Inc, Rahway, NJ 1989
   Google Scholar
• Harkey M R, Henderson G L, Gershwin M E, Stern J S, Hackman R M. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr. 2001; 73: 1101–6
   PubMed Web of Science ®Google Scholar
• Liberti L E, Marderosian A D. Evaluation of commercial ginseng products. J Pharm Sci. 1978; 67: 1487–9
   PubMed Web of Science ®Google Scholar
• Cui J, Garle M, Eneroth P, Björkhem I. What do commercial ginseng preparations contain?. Lancet 1994; 344: 134
   PubMed Web of Science ®Google Scholar
• Feifer A H, Fleshner N E, Klotz L. Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease. J Urol. 2002; 168: 150–4
   PubMed Web of Science ®Google Scholar
• de los Reyes G C, Koda R T. Determining hyperforin and hypericin content in eight brands of St. John's wort. Am J Health Syst Pharm. 2002; 59: 545–7
   PubMed Web of Science ®Google Scholar
• Gurley B J, Gardner S F, Hubbard M A. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm. 2000; 57: 963–9
   PubMed Web of Science ®Google Scholar
• Heptinstall S, Awang D C, Dawson B A, Kindack D, Knight D W, May J. Parthenolide content and bioactivity of fever few (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products. J Pharm Pharmacol. 1992; 44: 391–5
   PubMed Web of Science ®Google Scholar
• Webb G. “fX”: chemically adulterated product does not contain kava. Herbal Gram. 1997; 39: 9
   Google Scholar
• Kressmann S, Müller W E, Blume H H. Pharmaceutical quality of different Ginkgo biloba brands. J Pharm Pharmacol. 2002; 54: 661–9
   PubMed Web of Science ®Google Scholar
• Bass I S, Young A L. Dietary supplement health and education act: a legislative history and analysis. The Food and Drug Law Institute, Washington, DC 1996
   Google Scholar
• Ruth L. Dietary supplement quality control in the making. Anal Chem. 2002; 74: 312A–5A
   PubMed Web of Science ®Google Scholar
• Allen D. Not all dietary supplements are alike. America's Pharmacist. 2002; 124: 23–5
   Google Scholar
• Pharmacopeia U. S. Inside DSVP. 2002; 1: 1–3
   Google Scholar
• Senate Bill S. Congressional Record. 1330, August 2, 2001, S8751. <http://www.access.gpo.gov/su_docs/aces/aces150.html>
   Google Scholar